Form 4: Teladoc Health Executive Sells Shares Post-Vesting
Insider Transaction Report
Teladoc Health's BetterHelp President, Fernando M. Rodrigues, sold shares following RSU vesting under a pre-arranged trading plan.
Summary
- Fernando M. Rodrigues, President of BetterHelp at Teladoc Health, Inc. (TDOC), reported transactions involving the company's common stock.
- On December 1, 2025, 5,491 restricted stock units (RSUs) converted into common stock, increasing beneficial ownership to 5,491 shares.
- Also on December 1, 2025, an additional 1,042 RSUs converted into common stock, bringing the total beneficial ownership to 6,533 shares.
- On December 2, 2025, 2,324 shares were sold at a price of $7.488 per share to cover tax withholding obligations related to the RSU vesting.
- On December 3, 2025, the remaining 4,209 shares were sold at a price of $7.48 per share.
- All sales were conducted pursuant to a Rule 10b5-1 trading plan adopted on November 18, 2024, and amended on November 27, 2024.
- Following these transactions, the reporting person's direct beneficial ownership of common stock is 0 shares.
Sentiment
Score: 5
Explanation: The sentiment is neutral as this is a routine insider transaction involving the vesting and subsequent sale of shares, largely for tax purposes and under a pre-arranged trading plan, which is a common occurrence and not indicative of specific positive or negative company performance.
Positives
- The vesting of 6,533 restricted stock units represents the realization of compensation for the executive.
Negatives
- The sale of all vested shares, even if for tax purposes and under a 10b5-1 plan, reduces the executive's direct equity stake in the company.
Future Outlook
The filing does not contain forward-looking statements or guidance regarding the company's future performance or outlook, focusing solely on past insider transactions.
Industry Context
This Form 4 filing reports a routine insider transaction, specifically the vesting and subsequent sale of restricted stock units by a key executive. Such transactions are common in the industry as part of executive compensation and personal financial planning, often executed under pre-arranged Rule 10b5-1 plans to avoid accusations of trading on material non-public information.
Stakeholder Impact
- Shareholders: The sale of shares by an executive, even if routine, slightly increases the float and could be perceived differently by investors, though the impact is likely minimal given the context of a 10b5-1 plan and tax withholding.
- Employees: No direct impact on employees is indicated by this filing.
Next Steps
- Future vesting events for the remaining restricted stock units granted on December 1, 2023 (21,966 units) and March 19, 2024 (5,210 units) will occur according to their respective schedules.
Key Dates
| Date | Description |
|---|---|
| 12/01/2023 | Grant date for 65,894 restricted stock units, vesting one-third on the first anniversary, with the remainder in eight substantially equal quarterly installments. |
| 03/19/2024 | Grant date for 12,500 restricted stock units, vesting one-third on the first anniversary, with the remainder in eight substantially equal quarterly installments beginning on June 1, 2025. |
| 11/18/2024 | Date the Rule 10b5-1 trading plan was adopted by the reporting person. |
| 11/27/2024 | Date the Rule 10b5-1 trading plan was amended by the reporting person. |
| 06/01/2025 | Start date for quarterly vesting installments for the 12,500 restricted stock units granted on March 19, 2024. |
| 12/01/2025 | Date of conversion of 5,491 and 1,042 restricted stock units into common stock. |
| 12/02/2025 | Date of sale of 2,324 common shares to cover tax withholding obligations. |
| 12/03/2025 | Date of sale of 4,209 common shares under a Rule 10b5-1 trading plan. |
Keywords
Teladoc Health, TDOC, Form 4, Insider Transaction, Stock Sale, RSU Vesting, Rule 10b5-1, BetterHelp
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.